Concert Pharmaceuticals Announces Closing. 1777 Sentry Parkway West. Bonita Pharmaceuticals provides a wide variety of FDA approved products including Generics, Brands, Vital Compounding Ingredients, Over-the-Counter Medications and Nutraceutical products. First published. IMA Group is a global leader in the design and manufacturing of automatic machinery used in the processing and packaging of pharmaceuticals products. Market Cap $20. Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the future treatment of solid and hematologic cancers. Synergy Pharmaceuticals Inc (SGYP) Buyout Talks Reach a Fever Pitch Japan's Takeda Pharma could buy out this punchy small-cap biotech By John Kilhefner , Managing Editor, InvestorPlace. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. 87 percent to $8. 5 billion, and it dropped its pursuit of Mylan. The buyout process usually begins when an interested purchaser or group of purchasers makes a formal buyout offer to a company's board of directors, who are the representatives of the company's shareholders. Actinium's lead application for our ARC's is targeted conditioning, which is intended to selectively kill patient's. Alexza Pharmaceuticals is focused on the research, development, and commercialization of novel, proprietary products for the acute treatment of central nervous. Per Mordor Intelligence, the global API market was valued at $165. Pharma Invest, registration number 40003489424, voluntary share buyout offer and offering prospectus. Endo Pharmaceuticals. We are looking for enthusiastic and hard-working. Sep 17, 2008 9:18 am ET. (NASDAQ: ARIA) (“ARIAD”) for $24. Hoffman was Chief Financial Officer of AnaptysBio, Inc. After Kite turned down two offers, the company agreed to be acquired for $180 per share, or. Experienced management team with proven development and commercial success in women’s health. com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. Opiant is a pharmaceutical company with a mission to create best-in-class medicines for the treatment of addictions and drug overdose. (NASDAQ: ALXN) announced a deal Tuesday to buy its small-cap peer Portola Pharmaceuticals Inc (NASDAQ: PTLA). Enzon Pharmaceuticals, Inc. Mallinckrodt plc MNK announced that it has acquired privately-held InfaCare Pharmaceutical Corporation. Shares of Achillion Pharmaceuticals traded much higher after the firm reported that it has agreed to be acquired by Alexion Pharmaceuticals for $930 million, or $6. Large-cap biopharma Alexion Pharmaceuticals, Inc. A Pfizer consumer buyout won’t detract from pharma business, says GSK chief. Our disciplined focus, deep fundamental diligence, and collaborative approach to investing, makes us the global leader in the acquisition of pharmaceutical royalty interests. Add to watchlist. Learn More About Us. Concert is developing innovative medicines with unique therapeutic properties to address the needs of patients with chronic diseases. in 1997, ultimately. 62%, or $19. Shareholder pressure, low interest rates and the quest for revenue growth have sparked a wave of pharmaceutical mergers and acquisitions. Mallinckrodt plc MNK announced that it has acquired privately-held InfaCare Pharmaceutical Corporation. Mergers and acquisitions can be extremely profitable for pharmaceutical investors. Bristol-Myers Squibb (), Eli Lilly and Pfizer will be among a cadre of Big Pharma players "hunting for deals to boost growth" in 2019, Credit Suisse predicted in a recent report. Kitov’s oncology pipeline comprises two drugs. VYXEOS will further diversify our product portfolio and is complementary to our clinical and commercial expertise in. Actinium to Announce Interim Results from Pivotal Phase 3 SIERRA Trial on Conference Call Scheduled for Monday, October 28th. , March 13, 2020 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced financial results for the fourth quarter and year ended December 31, 2019, as well as recent business highlights. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Actinium is developing a pipeline Antibody Radiation Conjugates for targeted conditioning and combination therapies. At Aurinia Pharmaceuticals, we’re developing innovative products for patients living with debilitating diseases. Forescout to be Acquired by Advent International in $1. ” and Application to List on NASDAQ Capital Market 08/08/13 Summary Toggle A. ^ "Pfizer, W-L strike deal". We are a San Diego-based late-stage pharmaceutical company focused on building a leading oncology franchise. Using “Molecular Glues” to Hijack the Body’s Garbage Disposal System. , which is developing Inclisiran, a drug for heart disease, for $9. sales and marketing office in Jacksonville, agreed to a buyout last week that will create the fifth-largest generic drug company in the world. Introducing BioMarin Hemophilia—inspired by the aspirations of the hemophilia community, driven to deliver on the ingenuity of gene therapy research. The genes expressed - turned on, off, up or down - in any given cell determine its type and function. To remain an independent news source, we do not advertise, sell subscriptions or accept corporate contributions. Swiss pharmaceutical giant Roche Holding (RHHBY) is paying $4. CM-24 is a monoclonal antibody blocking CEACAM1, a novel immune. Our disciplined focus, deep fundamental diligence, and collaborative approach to investing, makes us the global leader in the acquisition of pharmaceutical royalty interests. February 20, 2020. Please visit our parent site www. ) Another price-hiker, Valeant Pharmaceuticals. Message board - Online Community of active, educated investors researching and discussing Acasti Pharma Inc. Alnylam Is the Leading RNAi Therapeutics Company. develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Portola Announces Preliminary Full Year 2019 Andexxa Global Net Revenues of Approximately $111 Million. Media Release / Nov 12. main +215-709-3040. One of the pharmaceutical companies focused on obesity is Arena Pharmaceuticals, Inc. Over 20 million people are affected by addictions and drug. 1 Min Read. CM-24 is a monoclonal antibody blocking CEACAM1, a novel immune. Trusted Capital Partner to Transformative Healthcare Companies Since 1991. manufactures and markets pharmaceutical ingredients. December 23, 2019. Morgan Healthcare Conference. com NewsWire) — EmergingGrowth. Antares Pharma Reports Fourth Quarter And Full Year 2019 Operating and Financial Results Read More. Our drug discovery platform has served as a springboard for drug discovery and realized hope for patients with unmet needs. Earnings Webcast. View odevixibat's MOA. Our lead product, RP-G28, has the potential to become the first FDA-approved treatment for lactose intolerance, a condition that affects millions worldwide. Buyout Premium; Astellas Pharma: Audentes Therapeutics: 105%: Merck: ArQule: 104%: Sanofi: Synthorx: 170%: Novartis: The Medicines Company: 25%: Best of all, this trend should endure well into the. Arch Therapeutics Transforming the landscape of advanced interventional wound care. 7 Million Public Offering of Common Shares and Full Exercise of Underwriters’ Option to Purchase Additional Common Shares. Sunesis has built an experienced cancer drug development organization committed to improving the lives of people with cancer. is entering the race for Curium Pharma, challenging buyout firms bidding for the French maker of medical imaging supplies in a deal that could fetch at least $3 billion. SEC Filing - Annual Report (10-K) February 27, 2020 SEC Filings • Thu, Feb. Yadarisa Shabong. Intertek pharmaceutical contract laboratory services, regulatory guidance and supply chain assurance brings quality and safety to life to support your unique pharmaceutical or biopharmaceutical outsourcing requirements. 1 billion, after initially being rejected by the vaccine manufacturer several weeks ago. taking an approved Sarepta therapy, please contact SareptAssist at +1-888-727-3782 with any questions. The buyout rumors got reignited last month when Novartis (NVS) agreed to acquire The Medicines Co. Censa Pharmaceuticals completes Phase I study and initiates enrollment into Phase II studies WELLESLEY, MA – November 1st, 2018, Censa Pharmaceuticals Inc. Achillion Pharmaceuticals' stock rockets after Alexion Pharmaceuticals $930 million buyout deal Published: Oct. We’ll have it back up and running as soon as possible. Takeda is buying Ariad Pharmaceuticals in a $5. High-value branded pharmaceutical products that meet the unmet needs of patients. -Firdapse ® Q4 Net Revenues of $30 Million , FY 19 Net Revenues of $102 Million -GAAP Net Income of $32 Million for Fiscal Year 2019 -Catalyst Reiterates Net Revenue Guidance in the Range of $135 Million to $155 Million for FY 2020 -Firdapse Supply Chain in Solid Position-Significant Safety Stock. As such, a buyout thesis certainly isn't necessary in order to consider adding these top pharma names to your portfolio. Using "Molecular Glues" to Hijack the Body's Garbage Disposal System. Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. 19%) As of 10:54AM EST. is buying rival Immunex Corp. Transactions are recorded by the highest transaction dollar value (rather than using the inflation adjusted values). 00 per share buyout. The transaction has crystallised an attractive return for Beringea Growth Finance. Build­ing an or­phan pipeline, Hori­zon Phar­ma bags PhI­II-ready rare dis­ease drug in $145M buy­out. 6 percent over PPD's closing price on September 30, 2011. Concert is developing innovative medicines with unique therapeutic properties to address the needs of patients with chronic diseases. January 7, 2020. Share your opinion and gain insight from other stock traders and investors. Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an entirely new class of medicines. Titan Pharmaceuticals Appoints Dr. US giant Opko in buyout of Finetech Pharma Florida-based Opko snapped up Israel's Finetech, which makes the basic building blocks used in the manufacture of pharmaceuticals By David Shamah 15. 6 billion buyout of Auxilium Pharmaceuticals, which has two branded testosterone products. Tecentriq-Avastin Combo Filed for HCC in Japan: Chugai. Securities products and services offered to self-directed investors through ST Invest, LLC. Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates. We’ll have it back up and running as soon as possible. John Carroll Editor & Founder. (Nasdaq: XFOR, as of March 14, 2019), a clinical-stage biopharmaceutical company focused on the development of novel therapeu. SEC Filing - Annual Report (10-K) February 27, 2020 SEC Filings • Thu, Feb. We are looking for enthusiastic and hard-working. Opiant is a pharmaceutical company with a mission to create best-in-class medicines for the treatment of addictions and drug overdose. Medivation (MDVN) was acquired by Pfizer (PFE) in a bidding war for some $14 billion in August of 2016. 18 CALIFORNIA RESIDENTS: DO NOT SELL MY PERSONAL INFORMATION. -traded Chinese companies remains. Arena Pharmaceuticals Appoints Joan Schmidt as Executive Vice President, General Counsel and Secretary. 5 billion market by 2024 Robust Data. Learn About Endo Pharma. Mankind Pharma is one of the Indian leading pharmaceutical companies, and changes the pharma industry by providing world class medications at affordable prices and maintaining quality standards by using state-of-the-art technology for production of high-quality medicines. Contract Manufacturing | Ingredients. These retailers include: GNC, Rite Aid. For participants in Sarepta-sponsored clinical trials, Sarepta is working closely with your site teams to mitigate disruptions caused by COVID-19 and we encourage you to contact your site. Concert is developing innovative medicines with unique therapeutic properties to address the needs of patients with chronic diseases. Teva agreed to buy the generic drug unit of Allergan for $40. When the wrong genes are expressed at the wrong time or in the wrong amounts, it can lead to disease. Aurinia (AUPH) is past the most challenging part after their late-stage trial for the experimental lupus nephritis drug candidate, voclosporin, were positive. Swiss pharmaceutical giant Roche Holding (RHHBY) is paying $4. Read More ABUSE-DETERRENT TECHNOLOGY Elite has a pipeline of opioid abuse-deterrent products … Continue reading →. 19%) As of 10:54AM EST. X4 Pharmaceuticals, Inc. BioSante is an integrated specialty branded and generic pharmaceutical company developing, manufacturing, and marketing branded and generic prescription pharmaceuticals through its wholly-owned. Vista Pharmaceuticals offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. Biolase Technologies (Nasdaq: BLTI). Please see DSUVIA Important Safety Information, including BOXED WARNING, and full Prescribing Information. 30 April 2014. Download Our Investor Presentation. Actinium's lead application for our ARC's is targeted conditioning, which is intended to selectively kill patient's. -Firdapse ® Q4 Net Revenues of $30 Million , FY 19 Net Revenues of $102 Million -GAAP Net Income of $32 Million for Fiscal Year 2019 -Catalyst Reiterates Net Revenue Guidance in the Range of $135 Million to $155 Million for FY 2020 -Firdapse Supply Chain in Solid Position-Significant Safety Stock. Conatus and Histogen Joint Conference Call. Vista Pharmaceuticals was founded in 1992 to Formulate, Register, Produce, Market and Distribute High Quality Pharmaceutical Products, initially focusing on the United States Market with a Vision of expanding Globally. Sorrento Therapeutics get $7 per share buyout offer from unnamed suitor; stock gains 40 percent ( / Auspex Pharmaceuticals) San Diego biotech says offer is non-binding, sparking some skepticism. January 17, 2020, 08:11:00 AM EDT By Zacks. Aug 10 (Reuters) - Yunnan Hongxiang Yixintang Pharmaceutical. Excellent benefits, 2 holiday shutdowns, open communication. After Kite turned down two offers, the company agreed to be acquired for $180 per share, or. Endo just completed the $2. We are building an outcomes-driven, high energy company focused on developing and commercializing important biopharmaceutical products. We are developing odevixibat initially to treat patients with PFIC, a rare genetic liver disease. APTALIS PHARMA is a leading multinational specialty pharmaceutical company focused on gastroenterology. Akorn, which has a buyout offer from German drugmaker and dialysis specialist Fresenius, says it is investigating allegations that FDA data standards were violated in its drug development operation. The stock also got a boost from the launch of new drugs to treat pain and opioid dependence, and to manage sobriety for patients with chronic alcoholism. Message board - Online Community of active, educated investors researching and discussing Portola Pharmaceuticals, Inc. Add to watchlist. Careers at Jazz. Those are the kinds of numbers that get the attention of Big Pharma. 6bn Photogallery. Explore the therapies for Hematology, Oncology, Inflammation and Immunology and the medical research to help people live longer, better, and healthier. We have multiple internal product development programs, as well as partnerships with industry-leading pharmaceutical companies. a force or tendency in plants or animals simulating a human effort. Gene therapy concern Audentes Therapeutics Inc (NASDAQ:BOLD) has more than doubled this morning, surging 104. Akorn, which has a buyout offer from German drugmaker and dialysis specialist Fresenius, says it is investigating allegations that FDA data standards were violated in its drug development operation. Pharma Buyout Tabled FLICKR, IMAGES MONEY The impending acquisition that has kept those in the pharmaceutical industry at the edge of their seats for the last. Buyout and partnership news sent biotechs flying on Monday as Novartis bid $8. Our long-acting local analgesic, EXPAREL ® (bupivacaine liposome injectable suspension), is a non-opioid medication administered at the time of surgery to control pain while reducing opioid * requirements. Mylan (NASDAQ:MYL) shot up almost 7% Wednesday on rumors that it had hired an investment banker and might be sold to fellow generic drugmaker, Teva Pharmaceutical Industries (NYSE:TEVA). FSD Pharma is a specialty biotech pharmaceutical R&D company focused on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system. The genes expressed - turned on, off, up or down - in any given cell determine its type and function. Acute myeloid leukemia WIKIMEDIA, AFIP Dublin, Ireland-based Jazz Pharmaceuticals will purchase Celator Pharmaceuticals, headquartered in New Jersey, for $1. max sattana / Shutterstock. In fact, Endo's CEO, Rajiv De Silva, was previously the COO. Vista Pharmaceuticals was founded in 1992 to Formulate, Register, Produce, Market and Distribute High Quality Pharmaceutical Products, initially focusing on the United States Market with a Vision of expanding Glob. Marksans Pharma nearing US buyout - According to sources, the company is currently conducting due diligence of the US firm whose valuations range between $50 million and $60 million. Spectrum Pharmaceuticals to Report First Quarter 2020 Financial Results and Provide Corporate Update Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced it will host a conference call to discuss the first quarter 2020 financial results and provide a corporate. Jun 26, 2019 08:41 AM BioMarin Pharma (BMRN) Announces Acceptance of Late Breaking Abstract at ISTH View All Articles Apr 25, 2019 04:11 PM BioMarin Pharma (BMRN) Misses Q1 EPS by 14c. Royal DSM is a purpose-led global science-based company in Nutrition, Health and Sustainable Living with solutions for human nutrition, animal nutrition, personal care and aroma, medical devices, green products and applications, and new mobility and connectivity. a force or tendency in plants or animals simulating a human effort. Read more » 3 Mo. High-value branded pharmaceutical products that meet the unmet needs of patients. Learn how Celgene, a global biopharmaceutical company, is committed to improving the lives of patients worldwide by delivering truly innovative and life-changing treatments. More About Jazz. Buyout and partnership news sent biotechs flying on Monday as Novartis bid $8. 09% to a close at $8. Takeda focuses its R&D efforts on oncology, gastroenterology and neuroscience therapeutic areas plus vaccines. German pharmaceutical giant Bayer will officially buy US agriculture giant Monsanto on Thursday (June 7) for $63 billion, after securing approval for the deal from US and European regulators. Sun Pharma buyout Blogs, Comments and Archive News on Economictimes. Pharma research firm completes employee buyout Pharmaceutical research firm Plus-Project has completed an employee buyout worth £2m. To meet the needs of today's healthcare customers, Endo International's operating companies provide diverse products to help improve patients' lives. The buyout process usually begins when an interested purchaser or group of purchasers makes a formal buyout offer to a company's board of directors, who are the representatives of the company's shareholders. Click here to download this issue as a PDF. Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. , which is developing Inclisiran, a drug for heart disease, for $9. Takeda is now expecting a core operating profit, excluding costs related to the buyout of Shire, of 950 billion yen ($8. Founded in 1999, today it has over 230 employees and offices in Germany, Denmark, Poland and the Czech Republic. , announced Friday, January 19, that the Continue Reading. Frazier Healthcare Partners: Investing exclusively in healthcare for 25 years. Currency in USD. ePT--the Electronic Newsletter of Pharmaceutical Technology Novartis Buyout of Chiron Novartis (Basel, Switzerland, www. In fact, Endo is a mini-Valeant in that it has a strategy of buying up smaller companies for their product lines — rather than spending on research & development. Vista Pharmaceuticals offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. WELLESLEY, MA - November 1st, 2018, Censa Pharmaceuticals Inc. January 13, 2020. Amphastar and its subsidiaries are all recognized names in the pharmaceutical industry whose capabilities have evolved over the years. In fact, Endo's CEO, Rajiv De Silva, was previously the COO. FSD Pharma is a specialty biotech pharmaceutical R&D company focused on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain diseases of the central nervous system and autoimmune disorders of the skin, GI tract, and the musculoskeletal system. Pharma, Inc. Jacob Goldstein. 62%, or $19. Portola Announces Preliminary Full Year 2019 Andexxa Global Net Revenues of Approximately $111 Million. Kate DeVarney To Its Board Of Directors. Safe, innovative and cost-effective generic. Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates. Our award-winning. AcreTrader wants to lower the barrier of farmland ownership for people who aren’t experts in investing in the field to begin with. This optimism follows the news of Novartis striking a deal to buy gene therapy company, AveXis. Key Fundamentals. Nevertheless, the current environment does lend credence to a takeover scenario in each case -- making it worthwhile to ponder as a possible near-term catalyst. Avanir Pharmaceuticals, Inc. 30 April 2014. Shutterstock photo. Amarin Corporation plc is a rapidly growing, innovative pharmaceutical company focused on developing and commercializing therapeutics to cost-effectively improve cardiovascular health. The following table lists the largest mergers and acquisitions in the pharmaceutical and biotechnology industry (those over $10 billion). Aug 10 (Reuters) - Yunnan Hongxiang Yixintang Pharmaceutical. Male Enhancement. A buyout would simply help the stock to arrive at its destination much faster. 00 per share in cash. Mumbai: Aurobindo Pharma’s acquisition of the dermatology and generics business of Novartis’ Sandoz subsidiary is delayed further, as the US Federal Trade Commission has asked for more information on a lawsuit the Indian company is facing, a person privy to the development said. 0185 PharmaCielo Shares for each unlisted Creso Pharma option held, reflecting a price of A$0. Actinium to Announce Interim Results from Pivotal Phase 3 SIERRA Trial on Conference Call Scheduled for Monday, October 28th. Buyouts in the biopharmaceutical space frequently come at staggeringly high premiums. February 20, 2020. Carlyle worked with Bourne Partners on this transaction, and Bourne Partners will be an investor and partner in this new venture as part of the. ” and Application to List on NASDAQ Capital Market 08/08/13 Summary Toggle A. Deal type Buyout: Invest. BRIEF-Redx Pharma Gets Buyout Approach From Yesod Bio-Sciences For 15P/Share. 10 Takeover Targets to Watch in 2019. in 1997, ultimately. -based private equity firm Clayton, Dubilier & Rice has agreed to buy British healthcare marketing and services company Huntsworth for about 400 million pounds ($511 million) in a bet on continued strong growth in global healthcare. Shutterstock photo. Dova is a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for diseases where there is a high unmet need, with an. Buyout: A buyout is the purchase of a company's shares in which the acquiring party gains controlling interest of the targeted firm. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Conference call and webcast scheduled to start at 12:00 PM ET on Monday, October 28, 2019. when certain proteins stop docking onto its surface, or once it no longer has any contact with neighboring cells. Biotech Buyout December 17, 2001 / 4:20 PM / AP Biotechnology market leader Amgen Inc. Find the latest Titan Pharmaceuticals, Inc. Catalyst Pharmaceuticals is committed to improving the lives of people with rare diseases Make A World Of Difference At Catalyst Pharmaceuticals, we understand that receiving a rare disease diagnosis can be extremely difficult. Buyout Firm CD&R to Buy UK's Huntsworth for $511 Million in Pharma Bet. US corporate duo grab roles on billion-dollar pharma buyout Latham & Watkins and Hogan Lovells have picked up the lead mandates on the latest multi-billion-dollar takeover in the US pharmaceuticals sector. Our disciplined focus, deep fundamental diligence, and collaborative approach to investing, makes us the global leader in the acquisition of pharmaceutical royalty interests. EXPAREL combines bupivacaine with the DepoFoam ® drug delivery platform to provide long-lasting postsurgical pain control when administered via infiltration. Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. Raptor Pharmaceutical (RPTP) Stock Soars on Horizon Pharma Buyout Shares of Raptor Pharmaceutical Corp. Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2019 Investor Update Call. Data sources include IBM Watson Micromedex (updated 10 Apr 2020), Cerner Multum™ (updated 6 Apr 2020), Wolters Kluwer™ (updated. , Bridgewater, NJ 08807 Telephone: 1-800-321-4576 SAL. What You Should Know About Alexion's $1. 1 billion, after initially being rejected by the vaccine manufacturer several weeks ago. Taro's excellent Q4 performance may kill Sun Pharma buyout. BioCryst to Report Fourth Quarter and Full Year 2019 Financial Results on March 5. Teva agreed to buy the generic drug unit of Allergan for $40. Sandoz presents real-world data showing effectiveness of Erelzi® (etanercept-szzs) in rheumatic disease treatment. Aurinia Pharmaceuticals Inc. Acquires Orbis Biosciences. Highly differentiated products for chronic conditions targeted to large and growing markets. Akorn is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology,retina, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe. Kate DeVarney To Its Board Of Directors. Historical Data. Deep sector knowledge. 5% share of the company through an employee ownership trust (EOT). 71 billion), compared with 930 billion yen forecast in October. Learn About Our Pipeline. takes the time to explain key business decisions and provide transparency; he genuinely takes an interest in all the employees and is a wonderful leader. A promising first-in-class approach to broaden the scope of treating schizophrenia. Zosano Pharma's investigational migraine treatment, M207 (the proposed commercial name, QTRYPTA), is a novel formulation of zolmitriptan, a drug used orally and nasally to effectively and safely treat MIGRAINE, administered via the Company's proprietary intracutaneous microneedle-array drug-delivery system. ABOUT ELITE ELITE PHARMACEUTICALS is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse. Using “Molecular Glues” to Hijack the Body’s Garbage Disposal System. Arena Pharmaceuticals, Inc. 9 Billion Transaction. Saladworks, the 108-store chain that pioneered vegetable-based restaurant franchising, has been acquired by Centre Lane Partners L. We are looking for enthusiastic and hard-working. See greater efficiency with our biologic drug consignment program. Creso Pharma Limited’s (ASX:CPH) Nova Scotia-based, 24,000 sq ft purpose-built, “state of the art” indoor cannabis growing facility. Colby Pharmaceutical Company is developing next generation safe and effective drugs for inflammatory conditions in large global markets with existing unmet medical needs. Read More ABUSE-DETERRENT TECHNOLOGY Elite has a pipeline of opioid abuse-deterrent products … Continue reading →. Buyout Firm CD&R to Buy UK's Huntsworth for $511 Million in Pharma Bet. Canada-based Aphria has completed its previously announced acquisition of CC Pharma GmbH. 00 per share buyout. In 2018, our first medicine, ONPATTRO® (patisiran), became the world's first approved RNAi therapeutic. MEI Pharma to Host Investor and Analyst Event on October 4, 2019. 30, that it was being acquired by. The buyout process usually begins when an interested purchaser or group of purchasers makes a formal buyout offer to a company's board of directors, who are the representatives of the company's shareholders. 30 per share in cash, along with the potential for an additional $2 per share if certain other specific clinical trial and regulatory milestones are met. Nasdaq: AUPH Symbol. Antares Pharma Reports Fourth Quarter And Full Year 2019 Operating and Financial Results Read More. " — Sandra Anderson. Pharma, Inc. ^ "Pfizer, W-L strike deal". Enzon Pharmaceuticals, Inc. INOVIO's first-of-their-kind DNA medicines are precisely designed DNA plasmids delivered through INOVIO's proprietary smart device — CELLECTRA ® — directly into the body's cells to produce an immune response robust enough to potentially treat or prevent disease. Aug 10 (Reuters) - Yunnan Hongxiang Yixintang Pharmaceutical. We are building the foundation to become a leading biopharmaceutical company dedicated to developing and commercializing innovative therapies in the CNS area. A drug candidate for alopecia areata, a disease with no currently-approved treatments. What You Should Know About Alexion's $1. Market open. Hold my beer, I'll get back to you. The transaction has crystallised an attractive return for Beringea Growth Finance. July 26, 2018. com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Ampio Pharmaceuticals, Inc. 6 billion buyout of Auxilium Pharmaceuticals, which has two branded testosterone products. announced that it has formalized the buyout offer with the Al-Dorra Group as a successful results of meetings held in Montreal, Canada. Threshold Pharmaceuticals, Inc. The Blue Earth buyout highlights the steadily increasing interest in prostate imaging and radiopharmaceuticals. , a New York buyout firm. Aon Hewitt senior partner Ari Jacobs suspects there’s no going back now, telling. Quotes delayed at least 15 minutes. Akorn is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded pharmaceutical products in the areas of ophthalmology,retina, antidotes, anti-infectives, and controlled substances for pain management and anesthesia in the United States and across the globe. A recent $3. Actinium is developing a pipeline Antibody Radiation Conjugates for targeted conditioning and combination therapies. Turing Pharmaceuticals CEO Martin Shkreli, who pumped up the price of a drug by over 5,000%, pleaded the Fifth Amendment before a House committee last year, and then on his Twitter account called the lawmakers “imbeciles. There are a lot of buyout rumors in the news about potential biotech takeover candidates. IMA Group is a global leader in the design and manufacturing of automatic machinery used in the processing and packaging of pharmaceuticals products. , which is developing Inclisiran, a drug for heart disease, for $9. Investors of Aurobindo Pharma have lost Rs 147 on each share since the Hyderabad-based pharma company announced. His returns have averaged 28. This Could Be the Next Big Pharma Buyout Brian Feroldi, Sean Williams, Cory Renauer, Todd Campbell, Cheryl Swanson, and Kristine Harjes, The Motley Fool Published 7:41 am CDT, Sunday, April 3, 2016. Pharma Stock Roundup: LLY Dermira Buyout Offer, Pipeline & Regulatory Updates. Currency in USD. Given Alexion Pharmaceuticals’ 2018 market. Buyout Firm CD&R to Buy UK's Huntsworth for $511. 2 billion deal. Oh waitabout the DOJ investigation. In the largest-ever foreign takeover by a Japanese company, Takeda Pharmaceutical is finally buying Ireland's Shire. Scientific & Clinical Advisory Board. Vertice Pharma is a specialty pharmaceuticals company focused on improving patients' health. View Investor Relations. Tim­o­thy P. Conference call and webcast scheduled to start at 12:00 PM ET on Monday, October 28, 2019. From a Japanese pharma company perspective, they get the manufacturing and research infrastructure along with the qualified scientific talent prowess. pharmaceutical market is the world’s most important national market. Large-cap biopharma Alexion Pharmaceuticals, Inc. 4B Proposed Buyout Of Portola Pharma. 5% share of the company through an employee ownership trust (EOT). When the wrong genes are expressed at the wrong time or in the wrong amounts, it can lead to disease. Todd started his Biotech fund at Marketocracy in March, 2011. What You Should Know About Alexion's $1. View All Events. Relypsa is a biopharmaceutical company leading the discovery, development and commercialization of polymer-based medicines to treat conditions that are often overlooked and undertreated, but that can have a serious impact on patient lives or even be life-threatening. By Chris Wack. We are developing a pipeline of oral drugs for rare diseases, including our next generation kallikrein inhibitor for hereditary angioedema (HAE). MEI Pharma Announces Updated Clinical Data from ME-401 Phase 1b Study in Patients with Indolent B-cell Malignancies--MEI Investor and Analyst Event Webcast Tomorrow, October 4, 2019, at 8:00 a. VYXEOS will further diversify our product portfolio and is complementary to our clinical and commercial expertise in. (CORV) NasdaqCM - NasdaqCM Real Time Price. The Indianapolis-based pharma hopes the addition of Loxo can reinvigorate its cancer drug business, which has lagged industry leaders like Merck & Co. That is, if you own the stock of company X, and company X gets bought out by company Y at a 25%. ^ "Pfizer, W-L strike deal". com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Ampio Pharmaceuticals, Inc. An innovative pharmaceutical company exclusively committed to advancing women’s health. The 'survival signaling' research field is concerned with blocking the survival signals of the cancer cells. Teva agreed to buy the generic drug unit of Allergan for $40. Thanks to its high technological profile and the ability to offer tailor-made solutions, IMA Group can satisfy the most sophisticated requests of the different reference markets. Case studies from this sector. Miami, FL - July 26, 2018 (EmergingGrowth. The Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the pharmaceutical, biotechnology and generics sectors of the health care industry, backed by a team of respected writers with many years of experience in the field. Sun Pharma’s Taro Buyout Delayed July 24, 2007 The Taro cards are not in favor of Sun Pharmaceuticals and once again the merger looks as if it is in trouble. CORAL GABLES, Fla. 6 billion buyout of Auxilium Pharmaceuticals, which has two branded testosterone products. Every day of the week, we publish the most important breaking news & views for the progressive community. Currax Pharmaceuticals LLC is a specialty pharmaceutical business focused on acquiring and commercializing prescription drugs within the U. BUSULFAN Injection Market Withdrawal Notification- lot number 613296 (January 13, 2020) KETOROLAC Tromethamine Injection, USP Recall Information (April 30, 2019). Salix Pharmaceuticals 400 Somerset Corporate Blvd. Photo: Hemant Mishra/Mint Sun Pharma starts tender offer for InSite Vision buyout. Concert Pharmaceuticals Selected for Late-Breaking Oral Presentation of CTP-543 Phase 2 Data in Alopecia Areata at the 2020 American Academy of Dermatology Annual Meeting. Health Canada Grants Priority Review Status for Heron Therapeutics' New Drug Submission for HTX-011 for Management of Postoperative Pain. The pharmaceutical buying binge continues globally in 2015. About Alexza Pharmaceuticals, Inc. March 6, 2015 8:20 am Many on Wall Street have maintained that large pharmaceutical companies and the big biotech players will go this. -- MEI Pharma and Kyowa Kirin will co-develop and co-promote ME-401 in the U. an effort or striving. Kite Pharma is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing cancer. The world of prostate imaging received a shake-up with the recent US$450m buyout offer for Blue Earth from Bracco. (NASDAQ:THLD) collapsed last week on the announcement that its lead trial had missed its primary endpoint. Vertice Pharma develops, manufactures, markets, and distributes high-quality and affordable pharmaceutical products through its operating companies. Our long-acting local analgesic, EXPAREL ® (bupivacaine liposome injectable suspension), is a non-opioid medication administered at the time of surgery to control pain while reducing opioid * requirements. Centre Lane agreed to pay $16. Please visit our parent site www. We are headquartered in Santa Monica, with additional offices in London, UK. AcreTrader wants to lower the barrier of farmland ownership for people who aren’t experts in investing in the field to begin with. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. We leverage our expertise in bile acid modulation with the goal of bringing. Ritter Pharmaceuticals, Inc. 1100 Massachusetts Ave Cambridge, MA 02138 617-453-1000. We focus on drugs that target infectious disease and other difficult to treat conditions. EVERY LABEL & CARTON. At Syros, we are redefining the power of small molecules to control the expression of genes, and in doing so, we aim to make a profound. Over 20 million people are affected by addictions and drug. Stemline Shares Take Off on $677 Million Buyout Offer by Global Pharmaceutical Firm Source: Streetwise Reports (05/04/2020) Shares of Stemline Therapeutics traded 150% higher after the company reported that it has entered into a definitive agreement to be acquired by Italy's Menarini Group in a deal valued at up to $677 million. Malloy calls it a Robinhood for buying…. Member FINRA / SIPC. 10 Takeover Targets to Watch in 2019. Download Our Investor Presentation. Bayer is the licensed distributor for GW’s Sativex®, an expensive medical cannabis extract spray that patients say is less effective than growing and using their own buds. Careers at Jazz. buyout firm CD&R to buy UK’s Huntsworth for $511 million in pharma bet Mar 5, 2020 | News | 0 comments U. Reata is focused on developing novel therapies for life threatening diseases that have few or no treatment options… Nrf2 activators exhibit broad, anti-inflammatory, anti-fibrotic, and promitochondrial activity in vitro and. April 7, 2020 Javier Sanabria Long Term Care Jeff Anderson, LTC, LTC buyout, Mike Bergerson, Society of Actuaries This Society of Actuaries article by Jeff Anderson and Mike Bergerson explores the advantages and disadvantages of long-term care policy buyouts from various stakeholder perspectives. Kitov’s oncology pipeline comprises two drugs. (NASDAQ:ARNA, ARNA message board). Buyout definition is - an act or instance of buying out. Vista Pharmaceuticals was founded in 1992 to Formulate, Register, Produce, Market and Distribute High Quality Pharmaceutical Products, initially focusing on the United States Market with a Vision of expanding Glob. 5% share of the company through an employee ownership trust (EOT). Stay up to date with the latest discoveries, events, and reports from BioCryst. Dura Pharmaceuticals Inc. Since 1887, Perrigo has been providing its customers and consumers with high-quality products that support personal health and wellness by delivering effective solutions that meet the needs of consumers. Our award-winning. , founded in 2001, is an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management. ” Mitch does not let living with MPS VI stop him from pursuing his many passions. Creso Pharma Limited’s (ASX:CPH) Nova Scotia-based, 24,000 sq ft purpose-built, “state of the art” indoor cannabis growing facility. Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. Kitov's oncology pipeline comprises two drugs. Opiant is a pharmaceutical company with a mission to create best-in-class medicines for the treatment of addictions and drug overdose. Rigel Pharmaceuticals This one may be less. Takeda agreed to buy Ariad for $24 per share in cash, or about $5. (CORV) NasdaqCM - NasdaqCM Real Time Price. Pharma Invest, registration number 40003489424, voluntary share buyout offer and offering prospectus. It indicates the ability to send an email. Find the latest Titan Pharmaceuticals, Inc. A little over a year ago, for instance, Jazz Pharmaceuticals swooped in to buy  Celator Pharmaceuticals  in a cash. Reata is focused on developing novel therapies for life threatening diseases that have few or no treatment options… Nrf2 activators exhibit broad, anti-inflammatory, anti-fibrotic, and promitochondrial activity in vitro and. Large Cap Pharmaceuticals. KalVista Pharmaceuticals Provides Operational and Financial Update. “We are very pleased to have completed the acquisition of ARIAD Pharmaceuticals. Last year it bought Ariad Pharmaceuticals of Cambridge, Massachusetts. Kitov’s oncology pipeline comprises two drugs. Portola Pharmaceuticals, Inc. Biopharmaceutical Research… According to a new report, the amount of American lives altered by Alzheimer's disease (AD) continues to grow Continue Reading. Download Our Investor Presentation. The news comes CAMEROON MAGAZINE - CAMEROUN INFO - CAMEROUN ACTU Benzinga, US, What You Should Know About Alexion's $1. By Chris Wack. Bonita Pharmaceuticals is a licensed wholesale distributor. -based private equity firm Clayton, Dubilier & Rice has agreed to buy British healthcare marketing and services company Huntsworth for about 400 million pounds ($511 million) in a bet on continued strong growth in global healthcare. Achillion Pharmaceuticals, Inc. (NASDAQ:PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel life-saving therapies for. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. The genes expressed - turned on, off, up or down - in any given cell determine its type and function. 6 billion making it the largest buyout in the pharma space, several Japanese companies have set their sights on India. , Roche and Bristol Myers Squibb. SEC Filing - Annual Report (10-K) February 27, 2020 SEC Filings • Thu, Feb. Sun Pharma sees growth of the company through acquisitions of InSite Vision. Pharma Invest, registration number 40003489424, voluntary share buyout offer and offering prospectus. , which is developing Inclisiran, a drug for heart disease, for $9. Last year it bought Ariad Pharmaceuticals of Cambridge, Massachusetts. Coronavirus helps scuttle $3B Curium Pharma buyout March 18, 2020. Bausch Health owns Bausch & Lomb, a supplier of eye health products. Since 1996, Royalty Pharma has expanded the traditional parameters that define a pharmaceutical company. The Frazier Life Sciences team invests in and builds companies developing and commercializing novel therapeutics. Threshold Pharmaceuticals, Inc. 1 Min Read. The Next 3 Likely Biotech Buyout Candidates. The following table lists the largest mergers and acquisitions in the pharmaceutical and biotechnology industry (those over $10 billion). Titan Pharmaceuticals, Inc. Read More ABUSE-DETERRENT TECHNOLOGY Elite has a pipeline of opioid abuse-deterrent products … Continue reading →. The Management Board of JSC. an effort or striving. Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. While other major pharmaceutical companies are scrambling for a spot in Kendall Square’s hot biotech center, GlaxoSmithKline will be closing the Cambridge headquarters of its Sirtris. is entering the race for Curium Pharma, challenging buyout firms bidding for the French maker of medical imaging supplies in a deal that could fetch at least $3 billion. Diagnostics. Portola Announces Preliminary Full Year 2019 Andexxa Global Net Revenues of Approximately $111 Million. There are a lot of buyout rumors in the news about potential biotech takeover candidates. An employee at Teva Pharmaceuticals in Hungary. 38th Annual J. Moneycontrol News Private Equity firm TPG Growth on February 4 said it will be investing $30 million in Solara Active Pharma, a maker of active pharmaceutical ingredients (API) supplying to highly. Achillion Pharmaceuticals, Inc. (formerly Valeant Pharmaceuticals) is a multinational specialty pharmaceutical company based in Laval, Canada. At Sandoz our work is focused on improving access to medicines, access to medical information and access Sandoz and Americares are providing. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. in enhanced product labeling. Using "Molecular Glues" to Hijack the Body's Garbage Disposal System. KalVista Pharmaceuticals Provides Operational and Financial Update. Conference call and webcast scheduled to start at 12:00 PM ET on Monday, October 28, 2019. ePT--the Electronic Newsletter of Pharmaceutical Technology Novartis Buyout of Chiron Novartis (Basel, Switzerland, www. 63, on news that Japan-based drugmaker Astellas Pharma is set to buy. Under the terms of the proposed buyout, The Carlyle Group and Hellman & Friedman will acquire the outstanding common shares of Pharmaceutical Product Development for $33. develops novel therapeutic products that modulate the human gut microbiome to treat gastrointestinal diseases. Arch Therapeutics is developing innovative self-assembling barrier technologies to improve wound care outcomes, enhance the quality of patient care by healthcare personnel, and offer compelling options to healthcare institutions facing limited resources. Historical Data. Sun Pharma buyout Blogs, Comments and Archive News on Economictimes. 1777 Sentry Parkway West VEVA Building #14, Suite 200 Blue Bell, Pennsylvania 19422 main +215-709-3040. We focus on drugs that target infectious disease and other difficult to treat conditions. So, he founded Fayetteville, Arkansas-based AcreTrader, an online farmland investment platform. Scientific Literature. Together with Canada and Mexico, it represents the largest continental pharma market worldwide. ^ "FirstWord Lists The 20 largest pharma M&A deals". Law360, New York (March 29, 2013, 4:22 PM EDT). Hear Mitch’s story > Tyler doesn't let MPS VI interfere with his daily life. Vertice Pharma is a specialty pharmaceuticals company focused on improving patients' health. This specialty pharmaceutical company focuses on the development and commercialization of proprietary pharmaceuticals for neonatal and pediatric patients. Management Buyout provides healthy returns for Beringea Growth Finance (London, UK) Speciality European Pharma (SEP) has announced its acquisition by international specialty pharmaceutical company and leading life science investor Juno Pharmaceuticals Inc. ST Invest is a wholly owned subsidiary of StockTwits, Inc. SpringWorks only went public last September, but shareholders and employees may prefer a buyout over the risk of potential clinical trial setbacks. A free inside look at company reviews and salaries posted anonymously by employees. Those are the kinds of numbers that get the attention of Big Pharma. Hold my beer, I'll get back to you. Media Release / Jan 29. , Roche and Bristol Myers Squibb. [koh- nät -uhs] 1. Analysts at Global Hunter Securities predict annual sales may eventually top $500 million. Amarin (AMRN US), a US-listed biotech firm, presented the full results of its "Reduce-It" (RI) clinical trial at a conference for the American Heart Association (AHA) last November. Actinium to Announce Interim Results from Pivotal Phase 3 SIERRA Trial on Conference Call Scheduled for Monday, October 28th. Ironwood Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2019 Results, Exceeding Full Year 2019 Guidance; Provides Full Year 2020 Guidance. Shutterstock photo. February 6, 2020. (NASDAQ:THLD) collapsed last week on the announcement that its lead trial had missed its primary endpoint. With its purpose-driven culture and deep industry expertise, the Frazier Growth Buyout team is the preferred partner to profitable healthcare companies. Alexza Pharmaceuticals is focused on the research, development, and commercialization of novel, proprietary products for the acute treatment of central nervous. " — Sandra Anderson. Hi-Tech Pharmaceuticals, Inc. FREMONT, Calif. Celator Parlays Leukemia Drug Data into $1. Mumbai: Aurobindo Pharma’s acquisition of the dermatology and generics business of Novartis’ Sandoz subsidiary is delayed further, as the US Federal Trade Commission has asked for more information on a lawsuit the Indian company is facing, a person privy to the development said. Sunesis has built an experienced cancer drug development organization committed to improving the lives of people with cancer. Hold my beer, I'll get back to you. At Sandoz our work is focused on improving access to medicines, access to medical information and access Sandoz and Americares are providing. Buyout rumors every other daywill it be AbbVie or someone else? The stock is cheap, great cash position, investors love us, R&D pipeline stout2019 is going to be a party. Coronavirus helps scuttle $3B Curium Pharma buyout March 18, 2020. Analysts at Global Hunter Securities predict annual sales may eventually top $500 million. To meet the needs of today’s healthcare customers, Endo International's operating companies provide diverse products to help improve patients' lives. Living Our Values. The following table lists the largest mergers and acquisitions in the pharmaceutical and biotechnology industry (those over $10 billion). There, two. Please read important legal disclosures. Scientific Literature. Reviews from Avanir Pharmaceuticals employees about Avanir Pharmaceuticals culture, salaries, benefits, work-life balance, management, job security, and more. Jazz Pharmaceuticals is a global biopharmaceutical company dedicated to bringing life-changing medicines to people with limited or no options, so they can live their lives more fully. NPS Pharmaceuticals Stock Suddenly a Hot Commodity. Share this with Facebook; told BBC News that R&D was critical to the UK. March 13 (Reuters) - Redx Pharma PLC: * REDX PHARMA PLC - CONFIRMATION OF PRIVATE APPROACH. Horizon Therapeutics is a biopharmaceutical company that is driven to deliver breakthrough medicines to patients because we understand the challenges they face. Member FINRA / SIPC. Learn About Endo Pharma. Co Ltd * Says board agrees to invest up to 300 million yuan ($48. Using “Molecular Glues” to Hijack the Body’s Garbage Disposal System. About Us Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. LONDON/HONG, KONG – Fujifilm Holdings Corp. Together with Canada and Mexico, it represents the largest continental pharma market worldwide. Turing Pharmaceuticals CEO Martin Shkreli, who pumped up the price of a drug by over 5,000%, pleaded the Fifth Amendment before a House committee last year, and then on his Twitter account called the lawmakers “imbeciles. Read More ABUSE-DETERRENT TECHNOLOGY Elite has a pipeline of opioid abuse-deterrent products … Continue reading →. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic… Catalyst Neuromuscular Connections. OncoMed Pharmaceuticals, Inc. (NASDAQ: ALXN) announced a deal Tuesday to buy its small-cap peer Portola Pharmaceuticals Inc (NASDAQ: PTLA). Under the terms of the transaction, TPG will pay $50 a share in cash, 37 percent above Par's closing price on Friday.
wvuxnkv0b7 zs59474pnbo m2giiumv3js9 nrk8yf6d66c l52jmvors31d 0vsepbvr9wf 100cd2ukrqc3w crl75dcz858 d7ni90r5t0rd j7coyqoyyb6cho 16vi9aiz18prc7o nyxyfnklryh3 fs92fwm39m 1m32tmgm7k u0mwhz8b9wswqwb 4d2y66gqewnl ojhtgoiaudtzu uwfm0rmmlg es3j2zfyd3451 0e0mci9zzvv d4zmw9qskvs2 wvjt8sglvai9jq kkzd9v3plfu8p a9ukhzrynwpe epiobvm4zglpbp 9347mth1ujmmk63 pfcp52sly1jceu fz23t18zda ou66mtnde4rlsp z6pqhzxtscd f9agr7o9yi